CP
SRI icon

Covalent Partners’s Stoneridge SRI Stock Holding History

Covalent Partners’s Portfolio SRI Stock Details SRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-96,687
Closed -$1.13M – 30
2013
Q2 		$1.13M Buy
+96,687
New +$895K 0.39% 28

Other funds holding SRI

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Covalent Partners's SRI Position: Q3 2013 in Review

Covalent Partners sold out of Stoneridge (SRI) in Q3 2013, closing a stake of 96,687 shares — an estimated $1.13M sold.

Covalent Partners first reported a position in SRI in Q2 2013 and held it in 1 quarter. The position peaked at $1.13M in Q2 2013. 128 funds tracked by Wall St. Rank hold SRI as of Q3 2013.

  • Covalent Partners reported no remaining Stoneridge position as of Q3 2013 after selling out during the quarter.
  • Covalent Partners sold 96,687 Stoneridge shares in Q3 2013, an estimated $1.13M.
  • Covalent Partners first reported a position in Stoneridge in Q2 2013 and held it in 1 quarter.
  • Covalent Partners's Stoneridge position peaked at $1.13M in Q2 2013.
  • 128 funds tracked by Wall St. Rank held Stoneridge as of Q3 2013.

Based on Covalent Partners's 13F filing for Q3 2013, filed 14 Nov 2013.